Delivery Order SPE2DE21D7010-SPE2D626F6249
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $3,220.96 for COROENT SMALL INTERLOCK spinal implant products on October 30, 2025. This fixed-price delivery order with economic price adjustment provisions is funded through the Defense Logistics Agency Medical Supply Chain, a defense-focused entity responsible for procuring medical supplies and equipment for...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The contract, valued at $2,860.94, is a delivery order for OSTEOCEL PRO medical devices. It has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 31, 2024. The contract is not associated with any set-aside designation, indicating Nuvasive competed for this...
- The Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order contract to Nuvasive, Inc., a medical device company, to provide OSTEOCEL PRO products. The $4,105.38 contract has a completion date of March 19, 2024 and does not involve any set-aside designations. Nuvasive, Inc. is the prime contractor, and its parent company is Transplant Technology Inc.'s Bone Bank Allografts division, which specializes in surgical implants and allografts for the Department of Veterans...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- This is a $5,721.88 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is for the delivery of OSTEOCEL PRO, a type of spinal implant. Nuvasive is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, which also supplies surgical implants and bone graft products to the federal government. The contract has an...
- This is a $2,860.94 fixed-price delivery order awarded to Nuvasive, Inc., a medical device company, by the Defense Logistics Agency Troop Support Medical. The contract is for the delivery of the company's OSTEOCEL PRO spinal implant product, which supports spinal surgery procedures. Nuvasive has previously provided a range of spinal implants, biologics, and surgical equipment to the Department of Veterans Affairs (VA) and Department of Defense (DoD) under various...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The $3,111.10 fixed-price contract with economic price adjustment is for the delivery of OSTEOCEL PRO, a spinal fusion product, with a period of performance through October 4, 2024. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device manufacturer, for the procurement of OSTEOCEL PRO spinal implant products. The $5,721.88 contract has an ultimate completion date of April 8, 2024. Nuvasive, Inc. is the prime contractor and is not a small business. The contract does not have any set-aside designation. Nuvasive, Inc. is a provider of spinal implants, instruments, biologics, and related equipment to...
- Nuvasive, Inc. was awarded a $21,488.67 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency, on April 29, 2025. The delivery order, which is not set-aside designated, requires completion by May 19, 2025, and will be performed in San Diego, California. As a leading medical device manufacturer specializing in spinal surgery products, Nuvasive supplies advanced spinal implants, fusion devices,...
- This is a delivery order awarded to Nuvasive, Inc., a medical device company, by the Defense Logistics Agency (DLA) for the provision of OSTEOCEL PRO spinal implants. The fixed-price contract, valued at $1,244.44, has an ultimate completion date of April 29, 2024. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts Division, which has previously been awarded multiple firm-fixed-price purchase orders from the Department of Veterans Affairs (VA) for surgical...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F6249Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $2,860.94 for OSTEOCEL PRO on October 28, 2025, with an ultimate completion date of November 18, 2025. This fixed-price delivery order with economic price adjustment mechanism was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a defense agency that procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. Performance will be conducted at Nuvasive's San Diego, California facility. OSTEOCEL PRO is a bone graft material and allograft product utilized in orthopedic and spinal surgical procedures. This delivery order is issued under Nuvasive's broader federal contract portfolio serving military and veteran healthcare systems with specialized spinal surgery products and implants. Nuvasive operates under its parent company's $8 million Indefinite Delivery/Indefinite Quantity Blanket Purchase Agreement with the Defense Health Agency, effective through March 2027, which streamlines procurement and enables rapid ordering of spinal medical devices and biologics across Department of Defense and Department of Veterans Affairs medical facilities nationwide. The company has demonstrated sustained capability in delivering critical orthopedic and neurosurgical technologies supporting the federal healthcare enterprise's medical readiness mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/28/25 |